Introducing our latest innovation in healthcare diagnostics: the Lab Based Immunoassay system. This cutting-edge technology is designed to revolutionize the way immunological tests are conducted, offering precise and accurate results for a wide range of conditions. Our Lab Based Immunoassay system utilizes state-of-the-art equipment and reagents to detect and measure specific substances in the blood or other bodily fluids. With its high sensitivity and specificity, this system is able to identify and quantify biomarkers associated with various diseases, including infectious diseases, autoimmune disorders, and cancers. One of the key features of our Lab Based Immunoassay system is its ability to automate the testing process, reducing the potential for human error and increasing efficiency. This automation also allows for a higher throughput of samples, making it an ideal solution for busy laboratories and diagnostic centers. In addition, our system offers a user-friendly interface and intuitive software, enabling healthcare professionals to easily interpret and report the test results. With its fast turnaround time and reliable performance, the Lab Based Immunoassay system is poised to improve the speed and accuracy of diagnostic testing, ultimately leading to better patient outcomes. We are excited to bring this advanced technology to the healthcare industry and believe that our Lab Based Immunoassay system will set a new standard for immunological testing. Join us in leading the way towards more precise and efficient diagnostics.

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T